ZeptoMetrix Corporation Files Patent Infringement Lawsuit Against Microbix Biosystems Inc.
Buffalo, NY (PRWEB) October 10, 2016 -- ZeptoMetrix™ Corporation, a renowned leader and innovator of products and services for infectious disease diagnostic development, has filed a Statement of Claim with the Canadian Federal Courts (Court File No. T-1672-16) against Microbix Biosystems Inc (Mississauga, ON) asserting allegations of infringement of 34 claims of its CANADA Patent No. 2,426,172 entitled Nucleic Acid Testing controls.
“We truly believe that competition is healthy and necessary for innovation and growth, however, we cannot refrain from taking action against competitors where we believe our protected intellectual property is being used without our consent. We owe it to our diagnostic development partners, to our owners and to our employees to protect our company which is why we have filed these allegations of infringement in Federal Court in Canada.” said Dr. Gregory R. Chiklis, President and CEO, ZeptoMetrix.
About ZeptoMetrix™ and NATtrol™
Founded in 1999 and headquartered in Buffalo, New York with additional facilities in Franklin, Massachusetts, ZeptoMetrix is a fully integrated biotechnology company, whose products and services support all phases of research & development, validation, manufacturing and commercialization of diagnostic tests.
Accurate and sensitive diagnostics are necessary to confirm that laboratories are providing patients with proper testing results. ZeptoMetrix’s patented NATtrol (Nucleic Acid Testing Controls) Molecular Controls are intact and inactivated microorganisms that contain their entire genetic sequences. ZeptoMetrix has developed hundreds of NATtrol based products with this technology that are utilized by academic researchers, health departments, government institutions, testing laboratories, proficiency organizations and diagnostic developers worldwide. ZeptoMetrix NATtrol products are used for research and development, assay validation and verification, technician training and for ongoing quality control, making them essential components for today’s fast growing molecular diagnostics market.
For more information, please contact:
ZeptoMetrix Corporation
(http://www.zeptometrix.com)
Customer Relations:
878 Main Street
Buffalo, NY 14202
716-882-0920
custserv(at)zeptometrix.com
Media:
Michael Hershfield, VP, Sales and Marketing
508-553-5852
mhershfield(at)zeptometrix.com
Michael A. Hershfield, [email protected], http://wwwzeptometrix.com, +1 508.553.5852, [email protected]
Share this article